Methionine synthase reductase polymorphisms are associated with serum osteocalcin levels in postmenopausal women

Experimental and Molecular Medicine

Volumn 38, Issue 5, 2006, Pages 519-524

  Duk, Jae Kim ^a   Byung, Lae Park ^b   Koh, Jung Min ^a   Ghi, Su Kim ^a   Lyoung, Hyo Kim ^b   Hyun, Sup Cheong ^b   Hyoung, Doo Shin ^b   Hong, Jung Min ^c   Kim, Tae Ho ^c   Shin, Hong In ^c,d   Park, Eui Kyun ^c,d   Kim, Shin Yoon ^c,e  

^a University of Ulsan College of Medicine   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Kyungpook National University   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

Author keywords

Bone density; Methionine synthase reductase; Osteocalcin; Polymorphism; Postmenopause

Indexed keywords

METHIONINE SYNTHASE REDUCTASE; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL;

EID: 33750725702     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2006.61     Document Type: Article

References (37)

1. Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res 2003;18:723-9
2. Bathum L, von Bornemann Hjelmborg J, Christiansen L, Madsen JS, Skytthe A, Christensen K. Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased risk of fractures: results from a population-based Danish twin study. Osteoporos Int 2004;15:659-64
3. Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, Storti S, Rizza A, Biagini A. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 2003;11:671-8
4. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984;1:1091-3
5. Cifuentes M, Johnson MA, Lewis RD, Heymsfield SB, Chowdhury HA, Modlesky CM, Shapses SA. Bone turnover and body weight relationships differ in normal-weight compared with heavier postmenopausal women. Osteoporos Int 2003;14:116-22
6. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990;5:5-11
7. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, Lipis P, Smit JH, van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attnenuation, and fractures in healthy elderly people. J Bone Miner Res 2005;20:921-9
8. Dimitrova KR, DeGroot K, Myers AK, Kim YD. Estrogen and homocysteine. Cardiovas Res 2002;53:577-88
9. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 1996;11:337-49
10. Gilfix BM. Hyperhomocysteinemia: genetic determinants and selected mouse models. Clin Invest Med 2003;26:121-32
11. Hall DA, Jordan-Starck TC, Loo RO, Ludwig ML, Matthews RG. Interaction of flavodoxin with cobalamin-dependent methionine synthase. Biochemistry 2000;39:10711-9
12. Hall DA, Vander Kooi CW, Stasik CN, Stevens SY, Zuiderweg ER, Matthews RG. Mapping the interaction between flovodoxin and its physiological partners flavodoxin reductase and cobalamin-dependent methionine synthase. Proc Natl Acad Sci USA 2001;98:9521-6
13. Hedrick PW. Gametic disequlibrium measures: proceed with caution. Genetics 1987;117:331-41
14. Hedrick P, Kumar S. Mutation and linkage disequlibrium in human mtDNA. Eur J Hum Genet 2001;9:969-72
15. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005;51:2348-53
16. Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 2004;279:18361-9
17. Kim DJ, Koh JM, Lee O, Kim NJ, Lee YS, Kim YS, Park JY, Lee KU, Kim GS. Homocysteine enhances apoptosis in human bone marrow stromal cells. Bone 2006 Apr 24; [Epub ahead of print]
18. Kim GS, Koh JM, Chang JS, Park BL, Kim LH, Park EK, Kim SY, Shin HD. Association of the OSCAR promoter polymorphism with BMD in postmenopausal women. J Bone Miner Res 2005;20:1342-8
19. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, Heng HH, Rommens JM, Scherer SW, Rosenblatt DS, Gravel RA. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998;95:3059-64
20. Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, Yoo KY, Ahn SH, Choe KJ, Hirvonen A, Noh DY. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 2004;36:116-21
21. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996;1315:159-62
22. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-9
23. Miyao M, Morita H, Hosoi T, Kurihara H, Inoue S, Hoshino S, Shiraki M, Yazaki Y, Ouchi Y. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int 2000;66:190-4
24. Nathan H. Osteophytes of the vertebral column: an anatomical study of their development according to age, race, and sex with considerations as to their etiology and significance. J Bone Joint Surg Am 1962;44A:243-68
25. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 2001;285:785-95
26. Olteanu H, Banerjee R. Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem 2001;38:35558-63
27. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002;41:13378-85
28. Page AE, Hayman AR, Andersson LMB, Chambers TJ, Warburton MJ. Degradation of bone matrix proteins by osteoclast cathepsins. Int J Biochem 1993;25:545-50
29. Parrot F, Redonnet-Vernhet I, Lacombe D, Gin H. Osteoporosis in late-diagnosed adult homocystinuric patients. J Inherit Metab Dis 2000;23:338-40
30. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a ramdomized controlled trial. JAMA 2005;293:1082-8
31. Song KS, Song JW, Choi JR, Kim HK, Shin JS, Kim JH. Homozygous V/V (677C to T) and D/D (2756G to A) variants in the methylenetetrahydrofolate and methionine synthase genes in a case of hyperhomocysteinemia with stroke at young age. Exp Mol Med 2001;33:106-9
32. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89
33. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41
34. Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, Quinlivan EP, Gregory JF 3rd, Theriaque DW, Kauwell GP. Methionine synthase reductase 66A → G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C → T variant. J Nutr 2004;134:2985-90
35. Villadsen MM, Bunger MH, Carstens M, Stenkjaer L, Langdahl BL. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int 2005;16:411-6
36. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202
37. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, Gravel RA, Rozen R. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-23